Wenger JD - Search Results

1

Rapid assessment tool for Haemophilus influenzae type b disease in developing countries.

Feikin DR, Nelson CB, Watt JP, Mohsni E, Wenger JD, Levine OS. Feikin DR, et al. Among authors: wenger jd. Emerg Infect Dis. 2004 Jul;10(7):1270-6. doi: 10.3201/eid1007.030737. Emerg Infect Dis. 2004. PMID: 15324548 Free PMC article.

2

Haemophilus influenzae type B infection.

Levine O, Wenger J, Perkins YB, Rosenstein N, Schuchat A. Levine O, et al. Bull World Health Organ. 1998;76 Suppl 2(Suppl 2):131-2. Bull World Health Organ. 1998. PMID: 10063691 Free PMC article. No abstract available.

3

Modeling insights into Haemophilus influenzae type b disease, transmission, and vaccine programs.

Jackson ML, Rose CE, Cohn A, Coronado F, Clark TA, Wenger JD, Bulkow L, Bruce MG, Messonnier NE, Hennessy TW. Jackson ML, et al. Among authors: wenger jd. Emerg Infect Dis. 2012 Jan;18(1):13-20. doi: 10.3201/eid1801.110336. Emerg Infect Dis. 2012. PMID: 22257582 Free PMC article.

4

Haemophilus influenzae serotype a invasive disease, Alaska, USA, 1983-2011.

Bruce MG, Zulz T, DeByle C, Singleton R, Hurlburt D, Bruden D, Rudolph K, Hennessy T, Klejka J, Wenger JD. Bruce MG, et al. Among authors: wenger jd. Emerg Infect Dis. 2013 Jun;19(6):932-7. doi: 10.3201/eid1906.121805. Emerg Infect Dis. 2013. PMID: 23735653 Free PMC article.

5

Defining the burden of Hib disease in India.

Levine OS, Wenger JD. Levine OS, et al. Among authors: wenger jd. Indian Pediatr. 2002 Jan;39(1):5-11. Indian Pediatr. 2002. PMID: 11805348 No abstract available.

6

Carriage of Haemophilus influenzae type b in children after widespread vaccination with conjugate Haemophilus influenzae type b vaccines.

Mohle-Boetani JC, Ajello G, Breneman E, Deaver KA, Harvey C, Plikaytis BD, Farley MM, Stephens DS, Wenger JD. Mohle-Boetani JC, et al. Among authors: wenger jd. Pediatr Infect Dis J. 1993 Jul;12(7):589-93. doi: 10.1097/00006454-199307000-00009. Pediatr Infect Dis J. 1993. PMID: 8346003

7

Introduction of Hib conjugate vaccines in the non-industrialized world: experience in four 'newly adopting' countries.

Wenger JD, DiFabio J, Landaverde JM, Levine OS, Gaafar T. Wenger JD, et al. Vaccine. 1999 Nov 12;18(7-8):736-42. doi: 10.1016/s0264-410x(99)00269-8. Vaccine. 1999. PMID: 10547434

8

Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. The Bacterial Meningitis Study Group.

Wenger JD, Hightower AW, Facklam RR, Gaventa S, Broome CV. Wenger JD, et al. J Infect Dis. 1990 Dec;162(6):1316-23. doi: 10.1093/infdis/162.6.1316. J Infect Dis. 1990. PMID: 2230261

9

Efficacy of meningococcal vaccine and barriers to vaccination.

Rosenstein N, Levine O, Taylor JP, Evans D, Plikaytis BD, Wenger JD, Perkins BA. Rosenstein N, et al. Among authors: wenger jd. JAMA. 1998 Feb 11;279(6):435-9. doi: 10.1001/jama.279.6.435. JAMA. 1998. PMID: 9466635

10

Invasive disease due to Haemophilus influenzae serotype f: clinical and epidemiologic characteristics in the H. influenzae serotype b vaccine era. The Haemophilus influenzae Study Group.

Urwin G, Krohn JA, Deaver-Robinson K, Wenger JD, Farley MM. Urwin G, et al. Among authors: wenger jd. Clin Infect Dis. 1996 Jun;22(6):1069-76. doi: 10.1093/clinids/22.6.1069. Clin Infect Dis. 1996. PMID: 8783712

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

134 results

Search Page

Filters